Table 1.
Characteristics of Patients With Incident MI by HF Status During Follow-up
Characteristics | All | Without HF | With HF |
---|---|---|---|
N | 1,081 | 853 | 228 |
Age, mean (SD), yrs | 64 (15) | 62 (15) | 72 (14)* |
Male, n (%) | 643 (60) | 539 (63) | 104 (46)* |
Smoking, n (%) | |||
Never | 443 (41) | 357 (42) | 86 (38) |
Past | 257 (24) | 196 (23) | 61 (27) |
Current | 381 (35) | 300 (35) | 81 (36) |
BMI, mean (SD), kg/m2 | 28.9 (6.4) | 29.0 (6.4) | 28.5 (6.4) |
Hypertension, % | 709 (66) | 524 (61) | 185 (81)* |
Hyperlipidemia, % | 675 (62) | 524 (61) | 151 (66) |
Diabetes, % | 201 (19) | 138 (16) | 63 (28)* |
Charlson comorbidity index, mean (SD) | 1.14 (1.57) | 0.93 (1.38) | 1.93 (1.96)* |
Anterior MI, % | 376 (35) | 265 (31) | 111 (49)* |
ST elevation MI, % | 252 (23) | 207 (24) | 45 (20) |
Peak cTnT, mean (SD), ng/ml | 1.96 (3.54) | 1.80 (3.04) | 2.58 (4.93)* |
Killip >1, % | 218 (20) | 107 (13) | 111 (50)* |
Reperfusion/revascularizaton, % | 661 (61) | 543 (64) | 118 (52)* |
Discharged with ACEi or ARB†, % | 617 (60) | 477 (58) | 140 (65) |
Discharge with beta-adrenergic blocker†, % |
867 (84) | 684 (84) | 183 (85) |
Discharged with a statin†, % | 820 (80) | 646 (79) | 174 (81) |
Discharged with aspirin†, % | 905 (88) | 727 (89) | 178 (82)* |
p < 0.05
Data for medications at discharge were available for 1,032 patients (48 died in hospital, 1 a day after discharge), of whom 216 had heart failure.
ACEi = angiotensin-converting enzyme inhibitor; ARB = angiotensin-receptor blocker; BMI = body mass index; cTnT = cardiac troponin T; HF = heart failure; MI = myocardial infarction.